Effect of galbanic acid, a sesquiterpene coumarin from Ferula Szowitsiana, as an inhibitor of efflux mechanism in resistant clinical isolates of Staphylococcus Aureus

Brazilian Journal of Microbiology

Volumn 41, Issue 3, 2010, Pages 574-580

  Bazzaz, Bibi Sedigheh Fazly ^a   Memariani, Zahra ^a   Khashyarmanesha, Zahra ^a   Iranshahi, Mehrdad ^a   Naderinasab, Mahbobeh ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Efflux pump inhibitor; Ferula szowitsiana; Galbanic acid; Staphylococcus aureus

Indexed keywords

BACTERIA (MICROORGANISMS); FERULA; FOENICULUM VULGARE; STAPHYLOCOCCUS AUREUS;

EID: 77954266291     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822010000300006     Document Type: Article

References (20)

1. Aeschlimann, J.R.; Dresser, L.D.; Kaatz, G.W.; Rybak, M.J. (1999). Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 43, 335-340.
2. Bambeke, F.V.; Balzi, E.; Tulkens, P.M. (2000). Antibiotic efflux pumps. Biochem. Pharmacol. 60, 457-470.
3. Brendwald, N.P.; Gill, M.J.; Wise, R. (1998). Prevalence of a putative efflux mechanism among fluoroquinolone resistant clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42, 2032-2035.
4. Ding, Y.; Onodera, Y,; Lee, J.C.; Hooper, D.C. (2008). NorB an efflux pump in Staphylococcus aureus strain MW2, contributes to bacterial fitness in abscesses. J. Bacteriol. 190, 7123-7129.
5. Eliopoulus, G.M.; Mollering, R.C.J. (1996). Antimicrobial combinations. In: Lorian, V. (ed). Antibiotics in Laboratory Medicine. The Williams and Wilkins Co. Baltimore, Md, p. 330-396.
6. Gemmell, C.G.; Goutcher, S.C.;, Reid, R.; Sturrock, R.D. (1997). Role of certain virulence factors in a murine model of Staphylococcus aureus arthritis. J. Medical Microbiol. 46, 208-213
7. Gibbons, S.; Oluwatuyi, M.; Kaatz, G.W. (2003). A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J. Antimicrob. Chemother. 51, 13-17.
8. Iranshahi, M.; Arfa, P.; Ramezani, M.; Jaafari, M.R.; Sadeghian, H.; Bassarello, C.; Piacente, S.; Pizza, C. (2007). Sesquiterpene coumarins from Ferula szowitsiana and in vitro antileishmanial activity of 7-prenyloxycoumarins against promastigotes. Phytochemistry, 68, 554-61.
9. Khan, I.A.; Mirza, Z.M.; Kumar, A.; Verma, V.; Qazi, G.N. (2006). Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus. Antimicrob. Agents Chemother, 50, 810-812.
10. Lomovskaya, O.; Walkis, W. (2001). Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. J. Mol. Microbiol. Biotechnol. 3, 225-236.
11. Madureira, A.M.; Molnár, A.; Abreu, P.M.; Molnár, J.; Ferreira, M.J. (2004). A new sesquiterpene-coumarin ether and a new abietane diterpene and their effects as inhibitors of P-glycoprotein. Planta Med. 70, 828-33.
12. Markham, P.N.; Westhaus, E.; Klyachko, K.; Johnson, M.E.; Neyfakh, A.A. (1999). Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob. Agents Chemother. 43, 2404-2408.
13. Mullin, S.; Mani, N.; Grossman, T.H. (2004). Inhibition of antibiotic efflux in bacteria by the novel multidrug resistance inhibitors biricodar (VX-710) and timcodar (VX-853). Antimicrob. Agents Chemother. 48, 4171-6.
14. National Committee for Clinical Laboratory Standards (2000). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
15. Neyfakh, A.A.; Borsch, C.M.; Kaatz, G.W. (1992). Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrob. Agents Chemother. 37, 128-129.
16. Neyfakh, A.A.; Bidnenko, V.F.; Chen, L.B. (1991). Efflux-Mediated Multidrug Resistance in Bacillus Subtilis: Similarities and Dissimilarities with the Mammalian System. National Academic of Sciences. 88, 4781-4785.
17. Piddock, L.J. (2006). Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev.19, 382-402.
18. Shahverdi, A.R.; Fakhimi, A.; Zarrini, Gh,; Dehghan, Gh.; Iranshahi, M. (2007). Galbanic acid from Ferula szowitsiana enhanced the antibacterial activity of penicillin G and cephalexin against Staphylococcus aureus. Biol. Pharmacol. Bull. 30, 1805-1807.
19. Stavri, M.; Piddock, L.J.; Gibbons, S. (2007). Bacterial efflux pumps inhibitors from natural sources. J. Antimicrob. Chemother. 59, 1247-1260.
20. Truong-Bolduc, Q.C.; Dunman, P.M.; Strahilevitz, J.; Projan, S.J.; Hooper, D.C. (2005). MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus. J. Bacteriol. 187, 2395-2405.